Vitamin D: a new anti-infective agent?

Area of Science:

• Immunology
• Endocrinology
• Infectious Diseases

Background:

• Historically, tuberculosis treatment involved sun exposure.
• 1,25-dihydroxyvitamin D3 stimulates cathelicidin production, crucial for innate immune defense against pathogens like Mycobacterium.
• Reduced sunlight exposure in winter correlates with increased respiratory infections due to lower vitamin D synthesis.

Purpose of the Study:

• To explore the role of 1,25-dihydroxyvitamin D3 in combating infections.
• To investigate the association between vitamin D levels and susceptibility to various infectious diseases.
• To understand the mechanisms by which vitamin D exerts protective effects against pathogens.

Main Methods:

• Review of existing literature on vitamin D, cathelicidins, and infectious diseases.
• Analysis of studies linking low vitamin D levels to infection incidence.
• Examination of the molecular pathways involving vitamin D in immune cell function.

Main Results:

• Low vitamin D levels are associated with increased risk of infections including respiratory, enteric, sepsis, influenza, and HIV.
• 1,25-dihydroxyvitamin D3 upregulates antimicrobial peptides like cathelicidin and β-defensin 2 in immune and epithelial cells.
• Vitamin D enhances the innate immune response against a wide range of pathogens.

Conclusions:

• Vitamin D plays a significant role in innate immunity and infection defense.
• Vitamin D may function as a broad-spectrum antimicrobial agent.
• Vitamin D supplementation could be a valuable adjuvant therapy for diverse infectious diseases.